ArticlePharmacology research & perspectives2019

Preclinical disposition of MGS0274 besylate, a prodrug of a potent group II metabotropic glutamate receptor agonist MGS0008 for the treatment of schizophrenia.

Kohnosuke Kinoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.